Other
Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports.
BMJ (Clinical research ed.) · 9 Jun 2026
Record
Publication details
- Authors
- Lang K
- Journal
- BMJ (Clinical research ed.)
- Publication date
- 9 Jun 2026
- Publication type
- Journal Article
- Evidence type
- Other
- Relevance classification
- Primary
- PubMed ID
- 42264536
- DOI
- 10.1136/bmj-2026-102036
- Language
- eng
- Linked clinical trial
- Not reported
Abstract
Abstract not reported by the source record.
Weekly briefing
The Retatrutide Report
The most important retatrutide clinical trial, research and regulatory developments, once a week.
No spam. Unsubscribe anytime. By subscribing, you agree to receive the Retatrutide Report by email. You can unsubscribe at any time. Privacy Policy.